Mechanisms of Yajieshaba in the treatment of liver fibrosis through the Keap1-Nrf2 signaling pathwayYuanmei Bai, Peixin Guo|Frontiers in Pharmacology|2023Cited by 4
DaiTongXiao improves gout nephropathy by inhibiting inflammatory response through the TLR4/MyD88/NF-κB pathwayFeifan Liu, Peixin Guo|Frontiers in Pharmacology|2024Cited by 3